Publications by authors named "Anneke Raney"

Claim this Profile
I
In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122.
Søren Ottosen, Todd B Parsley, Lu Yang, Karin Zeh, Leen-Jan van Doorn, Anneke K Raney

Antimicrob Agents Chemother· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitors.
Johnny Y Nagasawa, Jenny Song, Huanming Chen, Hong-Woo Kim, Julie Blazel, Anneke K Raney

Bioorg Med Chem Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects.
Graeme Moyle, Marta Boffito, Albrecht Stoehr, Armin Rieger, Zancong Shen, Anneke Raney

Antimicrob Agents Chemother· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Hydrazinopurine 2'-methyl ribonucleosides and their 5'-monophosphate prodrugs as potent hepatitis C virus inhibitors.
Esmir Gunic, Suetying Chow, Frank Rong, Kanda Ramasamy, Anneke Raney

Bioorg Med Chem Lett· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication.
Esmir Gunic, Jean-Luc Girardet, Kanda Ramasamy, Vesna Stoisavljevic-Petkov, Suetying Chow, Anneke Raney

Bioorg Med Chem Lett· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional control of hepatitis B virus.
Anneke K Raney

Methods Mol Med· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HEP DART 2003: Frontiers in drug development for viral hepatitis.
Anneke K Raney, Robert K Hamatake, Zhi Hong

Expert Opin Investig Drugs· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agents in clinical development for the treatment of chronic hepatitis B.
Anneke K Raney, Robert K Hamatake, Zhi Hong

Expert Opin Investig Drugs· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis